Agna Biopharmaceuticals has reportedly selected banks for its Hong Kong IPO.

According to sources, Chinese biotechnology company Agna Biopharmaceuticals Limited has selected a bank in Hong Kong for its initial public offering (IPO), with a financing size of up to several hundred million dollars. Sources revealed that the company, supported by Golden Tree Asset Management, is collaborating with Bank of America, CICC, Jefferies Financial Group Inc., and J.P. Morgan. They said the company has already submitted a confidential IPO application, but details such as size and timing are still being discussed.